Journal of the American Veterinary Medical Association · 1989 · 126 citations · 0 references
MedicineOncologyVeterinary PathologyChemotherapyHematologic OncologyMedical OncologyChemotherapy In Hematologic MalignanciesMalignant NeoplasmsVeterinary ChemotherapyCanine LymphomaChemotherapy Response AssessmentComplete Response AssessmentHistopathologic ExaminationLymphoma ChemotherapyLymphoma Treatment ResponsePartial Response AssessmentPrognostic Factors Analysis
The records of 103 cats with lymphoma that underwent chemotherapy were reviewed. Diagnosis was confirmed by cytologic or histopathologic examination of appropriate tissue specimens. Sixty-four cats (62%) had a complete response to chemotherapy (median survival time, 7 months); 21 cats (20%) had a partial response (median survival time, 2.5 months); and 18 cats had a minimal response (median survival time, 1.5 months). Seventy-seven cats (75%) died of recurrent or progressive lymphoma, 9 cats died of feline leukemia-related anemia, 13 cats died of unrelated causes, and 4 cats were alive. Stage of disease was significantly (P = 0.009) related to response to treatment, and stage of disease and FeLV status were both significantly (P = 0.002 and P less than 0.001, respectively) related to survival.